Phase 2 Schizophrenia Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People with a primary diagnosis of schizophrenia.
• People whose schizophrenia has not responded well to previous treatments (sometimes called "treatment-resistant" schizophrenia).
• People who need antipsychotic medication and are currently receiving standard treatment for their condition.
• People whose symptom severity scores fall within a specific range on a standard schizophrenia assessment scale (a score between 80 and 120) at the time of screening and at the start of the trial.

Who may not be able to join:

• People who have a primary mental health diagnosis other than schizophrenia, as defined by the current standard diagnostic guidelines (DSM-5-TR).
• People who are currently being treated with a medication called clozapine.
• People who are considered to be at risk of suicidal behaviour.
• People who have a serious or poorly controlled physical health condition that could affect their ability to take part in the trial.

Important: This trial may have additional eligibility requirements not listed here. Always verify eligibility with the trial site directly before applying.